1. Home
  2. FLGT vs HPI Comparison

FLGT vs HPI Comparison

Compare FLGT & HPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$18.80

Market Cap

537.6M

Sector

Health Care

ML Signal

HOLD

Logo John Hancock Preferred Income Fund of Beneficial Interest

HPI

John Hancock Preferred Income Fund of Beneficial Interest

HOLD

Current Price

$15.95

Market Cap

435.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLGT
HPI
Founded
2011
N/A
Country
United States
United States
Employees
1315
N/A
Industry
Medical Specialities
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
537.6M
435.6M
IPO Year
2016
2002

Fundamental Metrics

Financial Performance
Metric
FLGT
HPI
Price
$18.80
$15.95
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$28.33
N/A
AVG Volume (30 Days)
442.4K
47.9K
Earning Date
05-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,730,000.00
N/A
Revenue This Year
$10.09
N/A
Revenue Next Year
$12.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.46
$15.26
52 Week High
$31.04
$17.61

Technical Indicators

Market Signals
Indicator
FLGT
HPI
Relative Strength Index (RSI) 61.55 42.97
Support Level $13.91 $15.79
Resistance Level $19.93 $16.38
Average True Range (ATR) 0.85 0.18
MACD 0.06 -0.02
Stochastic Oscillator 65.30 20.10

Price Performance

Historical Comparison
FLGT
HPI

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

About HPI John Hancock Preferred Income Fund of Beneficial Interest

John Hancock Preferred Income Fund is a closed-end, diversified management investment company. Its primary investment objective is to provide a high-level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve its investment objectives by investing in securities that may be undervalued relative to similar securities in the marketplace. The fund's principal investment strategies include investing a majority of its assets in preferred stocks and other preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, and short-term investments.

Share on Social Networks: